RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Moura, Filipe [1 ]
Berg, David [1 ]
Bellavia, Andrea [1 ]
Mosenzon, Ofri [1 ]
Dwyer, Jamie [1 ]
Scirica, Benjamin M. [1 ]
Wiviott, Stephen [1 ]
Bhatt, Deepak L. [1 ]
Raz, Itamar [1 ]
Feinberg, Mark William [1 ]
Morrow, David A. [1 ]
Sabatine, Marc Steven [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1493-176
引用
收藏
页码：1808 / 1808
页数：1
相关论文
共 50 条
  • [21] The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
    Sanchez-Briales, Paula
    Vidas, Maria Marques
    Lopez-Sanchez, Paula
    Lopez-Illazquez, Maria Victoria
    Martin-Testillano, Lucia
    Vedat-Ali, Aylin
    Portoles, Jose
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [22] SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function
    Suijk, Danii L. S.
    van Baar, Michael J. B.
    van Bommel, Erik J. M.
    Iqbal, Zainab
    Krebber, Merle M.
    Vallon, Volker
    Touw, Daan
    Hoorn, Ewout J.
    Nieuwdorp, Max
    Kramer, Mark M. H.
    Joles, Jaap A.
    Bjornstad, Petter
    van Raalte, Daniel H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 663 - 671
  • [23] SGLT2 INHIBITION IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES
    Guthoff, M.
    Mahling, M.
    Nadalin, S.
    Heyne, N.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 32 - 32
  • [24] Should All Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Receive an SGLT2 Inhibitor?
    Barry, Arden R.
    Mitchelmore, Bradley R.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (04): : 282 - 285
  • [25] SGLT2 Inhibitors for the Prevention of Kidney Failure in Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (07): : 663 - 664
  • [26] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Megan Leila Baker
    Mark Anthony Perazella
    Journal of Nephrology, 2020, 33 : 985 - 994
  • [27] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Baker, Megan Leila
    Perazella, Mark Anthony
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 985 - 994
  • [28] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
    Scheen, Andre J.
    Delanaye, Pierre
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46
  • [29] SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
    Ele Ferrannini
    Anna Solini
    Nature Reviews Endocrinology, 2012, 8 : 495 - 502
  • [30] Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus
    Ribola, F. A.
    Cancado, F. B.
    Schoueri, J. H. M.
    De Toni, V. F.
    Medeiros, V. H. R.
    Feder, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 199 - 211
12345